Shares Outstanding History
Cash Position
Cash Position
The company has -11.8 months of cash left based on the quarterly cash burn of $-6.37 M and estimated current cash of $-25.13 M.
Commentary on Financial Condition
“Our ability to continue as a going concern requires that we obtain sufficient funding to finance our operations in the near term. We do not have sufficient resources available to fund our business beyond December 2025. To increase our cash runway, management plans to secure additional capital, potentially through a combination of public or private securities offerings, convertible debt financings, and/or strategic transactions, including potential licensing arrangements, alliances, and drug product collaborations focused on specified geographic markets and/or potential revenues from any future acquisitions of small companies with FDA approved products as a result of our new corporate strategy” (from November 2025 filing’s Liquidity and Capital Resources) Filed At: 2025-11-19
| 8-K | Form 8-K | 2026-07-21 |
| NT 10-K | Form NT 10-K | 2026-04-01 |
| 8-K | Form 8-K | 2026-01-07 |
| 8-K | Form 8-K | 2025-12-02 |
| 424B3 | Form 424B3 | 2025-11-21 |
| 10-Q | Form 10-Q | 2025-11-19 |
| NT 10-Q | Form NT 10-Q | 2025-11-14 |
| 424B3 | Form 424B3 | 2025-11-13 |